Jump to content

Keenly-watched COVID-19 vaccine 'won't be expensive', developer says


rooster59

Recommended Posts

Keenly-watched COVID-19 vaccine 'won't be expensive', developer says

By Kate Kelland

 

2020-05-15T151830Z_2_LYNXMPEG4E1CW_RTROPTP_4_HEALTH-CORONAVIRUS-VACCINE-OXFORD.JPG

Vial 1 of Box 1. This is the vaccine candidate to be used in Phase 1 clinical trial at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Sean Elias/Handout via REUTERS

 

LONDON (Reuters) - A keenly-watched COVID-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up, said the Oxford University professor co-leading its development.

 

Adrian Hill, director of Oxford's Jenner Institute, which has teamed up with the drugmaker AstraZeneca to develop the vaccine, said ensuring wide distribution and low cost have been central to the project from the start.

 

"This not going to be an expensive vaccine," Hill told Reuters in an interview. "It's going to be a single dose vaccine. It's going to be made for global supply and it's going to be made in many different locations. That was always our plan."

 

The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front runners in the global race to provide protection against the new coronavirus causing the COVID-19 pandemic.

 

Preliminary data from a small trial of the experimental vaccine in six monkeys found that some of the animals given a single shot developed antibodies against the virus within 14 days, and all developed protective antibodies within 28 days.

 

When the monkeys were exposed to the new coronavirus, the vaccine appeared to prevent damage to the lungs and kept the virus from making copies of itself there, although it was still actively replicating in the nose.

 

Hill said the data from the animal tests were "encouraging of course" and reinforced his team's high degree of confidence that ongoing human trials of the shot will also show positive results. The first signals on whether and how well it works could come as early as July or August.

 

Hill's team began early-stage human trials of the vaccine in April, making it one of only a handful to have reached that milestone.

 

Hill said that as of this week, more than 1,000 people have been dosed in the trial - with around half getting the experimental vaccine and the other half serving as a control group.

 

Asked about the progress of the human trials, Hill said he and his team "are not going to give a running commentary" but added: "You can conclude that if the trial is still running - as it certainly is - that would mean there have been no major upsets."

 

Almost 4.5 million people have been reported to be infected by the novel coronavirus globally and more than 301,000 have died, according to a Reuters tally.

 

Health and disease experts say a vaccine that protects people from the new coronavirus could help end the pandemic, but finding one that works and manufacturing enough doses is a huge challenge.

 

The ChAdOx vaccine, a type known as a recombinant viral vector vaccine, uses a weakened version of the common-cold virus spiked with proteins from the novel coronavirus to generate a response from the body's immune system.

 

Other vaccines in human trials include those by Moderna Inc, Pfizer Inc and BioNTech SE and China's CanSino Biologics Inc.

 

Hill told Reuters the ChAdOx1 project has at least seven manufacturing sites around the world. Those include India's Serum Institute as well as sites in Europe and China.

 

Hill has said that up to a million doses of the shot are already being manufactured and will be available by September, even before trials fully prove whether it works.

 

"The ambition is shared to get a low-priced, very, very extensively available vaccine as soon as possible," Hill said. "And one of the reasons that we chose Astrazeneca was because they shared that ambition and they were convincing that they could provide supply and large scale."

 

(Reporting by Kate Kelland; Editing by Peter Graff)

 

reuters_logo.jpg

-- © Copyright Reuters 2020-05-16
 

 

 

  • Like 2
Link to comment
Share on other sites

Won't be expensive ..... or available in less than a year ..... or fully effective ..... or widely used due to Bronze Age religious resistance and tinfoil hat-wearers ..... or a way to eradicate COVID seeing as how only one disease has ever been eradicated by a vaccine - and since when has Reuters taken paid advertorials?

  • Sad 1
  • Haha 1
Link to comment
Share on other sites

1 hour ago, Kinnock said:

Won't be expensive ..... or available in less than a year ..... or fully effective ..... or widely used due to Bronze Age religious resistance and tinfoil hat-wearers ..... or a way to eradicate COVID seeing as how only one disease has ever been eradicated by a vaccine - and since when has Reuters taken paid advertorials?

What disease was eradicated by a vaccine?

Link to comment
Share on other sites

When the SARS vaccine was being developed it stumbled at this stage because the animals developed "immune-enhanced disease" which is when the vaccine triggers a worse response than the disease itself.

 

So I've got a glimmer of hope for this vaccine, it sounds promising but so many tests to still overcome. There's 500 people in the UK with it in their systems right now so it won't be long before we have further results.

  • Thanks 1
Link to comment
Share on other sites

5 hours ago, Heppinger said:

What disease was eradicated by a vaccine?

Aids has been around for 35 years without a vaccine and herpes 50 years. Now big pharma is going to pull one out of their asses in less than a year? Anyone for more Kool-Aid?

Edited by 1duckyboy
  • Like 1
Link to comment
Share on other sites

2 hours ago, 1duckyboy said:

Aids has been around for 35 years without a vaccine and herpes 50 years. Now big pharma is going to pull one out of their asses in less than a year? Anyone for more Kool-Aid?

 

1. The Institute referred to in the article is not "Big Pharma" (though they are also scrambling to find a vaccine).

 

2. Hardly has to he pulled out of thin air. They were already far along on a vaccine for SARS and had already developed a technology applicable to this virus.

 

 

  • Like 1
  • Thanks 1
Link to comment
Share on other sites

Just now, Sheryl said:

 

1. The non-profit Institute referred to in the article is not "Big Pharma" (though the private companies are indeed t also scrambling to find a vaccine).

 

2. Hardly has to he pulled out of thin air. They were already far along on a vaccine for SARS and had already developed a technology applicable to this virus.

 

 

 

Link to comment
Share on other sites

1 hour ago, anterian said:

Polio is getting close.

 

Yes, true - but that vaccine was first introduced in 1955, so it's not a quick process, and the last two countries are Afghanistan and Pakistan, which highlights my point about Bronze Age beliefs being one barrier.

Link to comment
Share on other sites

14 hours ago, Kinnock said:

Won't be expensive ..... or available in less than a year ..... or fully effective ..... or widely used due to Bronze Age religious resistance and tinfoil hat-wearers ..... or a way to eradicate COVID seeing as how only one disease has ever been eradicated by a vaccine - and since when has Reuters taken paid advertorials?

Spot on. And who's to say what's "expensive" or not? Even worse.... the precedent has been set. Need to make a few billion. Let some virus spread *by accident* then ride on on the big white horse to save us all with a vaccine. And just look at all the sheeple getting in line as ordered.

  • Like 2
  • Confused 1
Link to comment
Share on other sites

4 minutes ago, Bkk Brian said:

Both partners have agreed to operate on a not-for-profit basis

The Catholic Church is not-for-profit, reportedly worth 30 billion.

 

NFP, ok ok.  You have a salary of 10 billion?  no problem.  we have to pay salaries to keep our company "up and running".  don't worry, we are not-for-profit.  ok ok  

 

 

  • Like 2
Link to comment
Share on other sites

Just now, Ventenio said:

The Catholic Church is not-for-profit, reportedly worth 30 billion.

 

NFP, ok ok.  You have a salary of 10 billion?  no problem.  we have to pay salaries to keep our company "up and running".  don't worry, we are not-for-profit.  ok ok  

 

 

Jesus.................

Link to comment
Share on other sites

6 minutes ago, Ventenio said:

The Catholic Church is not-for-profit, reportedly worth 30 billion.

 

NFP, ok ok.  You have a salary of 10 billion?  no problem.  we have to pay salaries to keep our company "up and running".  don't worry, we are not-for-profit.  ok ok  

 

 

Of course "non-profit" is a scam. I could form a "non-profit" and give myself a million dollar salary. It's amazing so many people are fooled by this.

  • Like 1
  • Confused 1
Link to comment
Share on other sites

16 minutes ago, Bkk Brian said:

Both partners have agreed to operate on a not-for-profit basis for the duration of the coronavirus pandemic, with only the costs of production and distribution being covered. 

 

http://www.ox.ac.uk/news/2020-04-30-landmark-partnership-announced-development-covid-19-vaccine

 

Of course some people will still get on their high horse and demand it is free or they operate at a loss

I don't demand anyone do anything for free or at a loss. That sounds more like a leftist thing. And I'll believe the "non-profit" claim when I see it. Anyone can say they're going to do anything.

  • Confused 1
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.




×
×
  • Create New...